Entrada Therapeutics (TRDA) EBIT Margin (2023 - 2026)
Entrada Therapeutics' EBIT Margin came in at -5007.02% for Q2 2026, down 2604.50 percentage points from -2402.51% a year earlier and down 172.39 percentage points from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) EBIT Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Entrada Therapeutics reported EBIT Margin of -3767.07%, down 3646.07 percentage points year-over-year; for FY2025, it was -621.13%, down 643.44 percentage points from FY2024.
- Going back by year, EBIT Margin was 22.30% in FY2024 (+24.75 pp) and -2.45% in FY2023.
- The Q2 2026 figure represents the lowest quarterly EBIT Margin in data going back to Q1 2023.
- Year-over-year, EBIT Margin has declined for eight consecutive quarters, with an average year-over-year change of -2017.75 percentage points over the last eight quarters.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2024 (a gain of 146.12 percentage points), and the weakest in Q1 2026 (a drop of 4728.64 percentage points).
- Business Quant data shows TRDA's EBIT Margin at -4834.63% (Q1 2026), -3249.27% (Q4 2025) and -2915.18% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | -5,007.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,007.02% |
| Mar 31, 2026 | -4,834.63% |
| Dec 31, 2025 | -3,249.27% |
| Sep 30, 2025 | -2,915.18% |
| Jun 30, 2025 | -2,402.51% |
| Mar 31, 2025 | -105.99% |
| Dec 31, 2024 | -15.69% |
| Sep 30, 2024 | -110.67% |
| Jun 30, 2024 | 56.42% |
| Mar 31, 2024 | 35.71% |
| Dec 31, 2023 | 11.72% |
| Sep 30, 2023 | 32.04% |
| Jun 30, 2023 | -89.70% |
| Mar 31, 2023 | -22.88% |
API Access
Entrada Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();